As of 2026-10-02, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (8.06) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -2831.6%.
The range of the Relative Valuation is (4.06) - (12.13) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 34.2x | 22.6x |
| Forward P/E multiples | 11.4x - 34.4x | 22.9x |
| Fair Price | (4.06) - (12.13) | (8.06) |
| Upside | -1475.1% - -4213.3% | -2831.6% |
| Date | P/E |